<?xml version="1.0" encoding="UTF-8"?>
<Label drug="antizol" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">    ADVERSE REACTIONS

  The most frequent adverse events reported as drug-related or unknown relationship to study drug in the 78 patients and 63 normal volunteers who received Antizol  (r)  (fomepizole) Injection were headache (14%), nausea (11%), and dizziness, increased drowsiness, and bad taste/metallic taste (6% each). All other adverse events in this population were reported in approximately 3% or fewer of those receiving Antizol  (r)   and were as follows:      



   Body as a Whole:  Abdominal pain, fever, multiorgan system failure, pain during Antizol  (r)  injection, inflammation at injection site, lumbalgia/backache, hangover



   Cardiovascular:  Sinus bradycardia/bradycardia, phlebosclerosis, tachycardia, phlebitis, shock, hypotension     



   Gastrointestinal:  Vomiting, diarrhea, dyspepsia, heartburn, decreased appetite, transient transaminitis



   Hemic/Lymphatic:  Eosinophilia/hypereosinophilia, lymphangitis, disseminated intravascular coagulation, anemia     



   Nervous:  Lightheadedness, seizure, agitation, feeling drunk, facial flush, vertigo, nystagmus, anxiety, "felt strange", decreased environmental awareness



   Respiratory:  Hiccups, pharyngitis     



   Skin/Appendages:  Application site reaction, rash



   Special Senses:  Abnormal smell, speech/visual disturbances, transient blurred vision, roar in ear     



   Urogenital:  Anuria
</Section>
  </Text>
  <Mentions />
  <Relations />
  <Reactions />
</Label>
